FDA Import Refusal AEK-2043394-9/3/1 — Novartis Pharma Schweizerhalle Ag
The FDA refused shipment AEK-2043394-9/3/1 from Novartis Pharma Schweizerhalle Ag (Switzerland) on Apr 20, 2016. The refused product falls under Drugs and Biologics — XYLOMETAZOLINE HCL (ADRENERGIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Apr 20, 2016
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 60CBK53 XYLOMETAZOLINE HCL (ADRENERGIC)
- Charges
- 75